An investigation to determine the efficacy and safety of lentivirus mediated FXN gene delivery for the correction of Friedreich ataxia
Funder: Ataxia UKDuration: October 2017 - September 2018
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Professor Michael Themis Professor - Gene Therapy and Genotoxicity (Principal investigator)
T: +44 (0)1895 267252
E: michael.themis@brunel.ac.uk |
+44 (0)1895 267252 | michael.themis@brunel.ac.uk | Heinz Wolff 235 |